Goodwill

6 Months Ended

Dec. 31, 2013

GOODWILL

The following table summarizes the changes between June 30, 2013 and December 31, 2013 in the carrying amount of goodwill in total and by reporting segment:



(Dollars in millions)	Oral Technologies		Medication Delivery Solutions		Development & Clinical Services		Total
Balance at June 30, 2013 ⁽¹⁾	$	833.2	$	—	$	190.2	$	1,023.4
Additions/(impairments)⁽²⁾	33.1		—		—		33.1
Foreign currency translation adjustments	15.2		—		9.8		25.0
Balance at December 31, 2013	$	881.5	$	—	$	200.0	$	1,081.5


(1)	The opening balance is reflective of historical impairment charges related to the Medication Delivery Solutions segment of approximately $158.0 million.


(2)	Acquired goodwill of $33.1 million in our Oral Technologies segment was generated from acquisitions in Brazil and China during the six months ended December 31, 2013.

No goodwill impairment charges were required during the current or comparable prior year period. When required, impairment charges are recorded within the Consolidated Statement of Operations as Impairment charges and (gain)/loss on sale of assets.

Catalent Pharma Solutions, Inc. 10-Q